# US 2021/0275538 A1 · Noribogaine compositions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0275538 A1
- Document ID: US20210275538A1
- Status: Published application
- Kind: A1
- Application number: 17/202,985
- Filed: 2021-03-16
- Published: 2021-09-09
- Earliest claimed: 2010-07-23
- Assignees: Demerx, Inc.
- Applicants: DemeRx, Inc.
- Inventors: Robert M. Moriarty; Deborah C. Mash
- Web page: https://patentgrep.com/patent/US20210275538A1

## CPC

- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 25/30: for treating abuse or dependence
- C07D 487/14: Ortho-condensed systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Disclosed are noribogaine compositions comprising a very high level of the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and not more than 0.5 wt % of ibogaine relative to the total amount of noribogaine.

## Claims

### Claim 1

A composition comprising noribogaine wherein at least 95% of the noribogaine is present as the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and further wherein said composition comprises not more than 0.5 wt % ibogaine relative to the total amount of noribogaine.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said composition comprises not more than 0.3 wt % ibogaine relative to the total amount of noribogaine.

### Claim 3 (depends on 1)

The composition of claim 1, wherein said composition comprises not more than 0.1 wt % ibogaine relative to the total amount of noribogaine.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said composition comprises less than 800 ppm ibogaine.

### Claim 5 (depends on 1)

The composition of claim 1, wherein at least 98% of the noribogaine is present as the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer.

### Claim 6

A composition comprising noribogaine wherein at least 98% of the noribogaine is present as the 2(R), 4(S), 5(S), 6(S) and 18(R) enantiomer and further wherein said composition comprises not more than 0.5 wt % ibogaine relative to the total amount of noribogaine.

### Claim 7 (depends on 6)

The composition of claim 6, wherein said composition comprises not more than 0.3 wt % ibogaine relative to the total amount of noribogaine.

### Claim 8 (depends on 6)

The composition of claim 6, wherein said composition comprises not more than 0.1 wt % ibogaine relative to the total amount of noribogaine.

### Claim 9

A composition comprising noribogaine hydrochloride and isopropanol.

### Claim 10

A composition comprising noribogaine, hydrochloric acid at a concentration of 5M, and isopropanol, wherein the composition has a temperature of from 45 to 55° C.

### Claim 11

A composition comprising noribogaine, silica gel, methylene chloride, acetonitrile and an organic base.

### Claim 12

A composition comprising solid noribogaine hydrochloride and isopropanol.
